BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18844342)

  • 1. Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity.
    Ruiz J; Rodríguez V; Cutillas N; López G; Bautista D
    Inorg Chem; 2008 Nov; 47(21):10025-36. PubMed ID: 18844342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and reactivity of Ir(I) and Ir(III) complexes with MeNH2, Me2C=NR (R = H, Me), C,N-C6H4{C(Me)=N(Me)}-2, and N,N'-RN=C(Me)CH2C(Me2)NHR (R = H, Me) ligands.
    Vicente J; Chicote MT; Vicente-Hernández I; Bautista D
    Inorg Chem; 2008 Oct; 47(20):9592-605. PubMed ID: 18808115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of acetimino complexes of Pt(II) and Pt(IV) and the first heteronuclear mu-acetimido complexes.
    Vicente J; Chicote MT; Guerrero R; Vicente-Hernandez I; Jones PG; Bautista D
    Inorg Chem; 2006 Jun; 45(13):5201-9. PubMed ID: 16780345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds.
    Ruiz J; Lorenzo J; Sanglas L; Cutillas N; Vicente C; Villa MD; Avilés FX; López G; Moreno V; Pérez J; Bautista D
    Inorg Chem; 2006 Aug; 45(16):6347-60. PubMed ID: 16878945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA.
    Ruiz J; Cutillas N; Vicente C; Villa MD; López G; Lorenzo J; Avilés FX; Moreno V; Bautista D
    Inorg Chem; 2005 Oct; 44(21):7365-76. PubMed ID: 16212362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel C,N-chelate platinum(II) antitumor complexes bearing a lipophilic ethisterone pendant.
    Ruiz J; Rodríguez V; Cutillas N; Espinosa A; Hannon MJ
    J Inorg Biochem; 2011 Apr; 105(4):525-31. PubMed ID: 21334280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antitumor activity of platinum acetonimine complexes.
    Boccarelli A; Intini FP; Sasanelli R; Sivo MF; Coluccia M; Natile G
    J Med Chem; 2006 Jan; 49(2):829-37. PubMed ID: 16420068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the reactivity toward ketones of new methyl amino complexes of Rh(III) and Ag(I). Synthesis of ortho-rhodiated acetophenone methyl imine complexes.
    Vicente J; Chicote MT; Vicente-Hernandez I; Bautista D
    Inorg Chem; 2007 Oct; 46(21):8939-49. PubMed ID: 17880206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New palladium(II) and platinum(II) complexes with 9-aminoacridine: structures, luminiscence, theoretical calculations, and antitumor activity.
    Ruiz J; Lorenzo J; Vicente C; López G; María López-de-Luzuriaga J; Monge M; Avilés FX; Bautista D; Moreno V; Laguna A
    Inorg Chem; 2008 Aug; 47(15):6990-7001. PubMed ID: 18593114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
    ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activity of a C,N-cycloplatinated(II) complex with a potentially intercalative anthraquinone pendant.
    Ruiz J; Vicente C; de Haro C; Espinosa A
    Inorg Chem; 2011 Mar; 50(6):2151-8. PubMed ID: 21314142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
    Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
    Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
    J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.